8-K: Vireo Growth Q3 Revenue Soars 264% on M&A, Minnesota Adult-Use Launch

Vireo Growth Inc. reported a 264% year-over-year revenue increase to $91.7 million in Q3 2025, driven by strategic acquisitions and the launch of adult-use cannabis sales in Minnesota.

Summary

• GAAP revenue for Q3 2025 reached $91.7 million, a 264.2% increase from $25.2 million in Q3 2024.
• Adjusted EBITDA for Q3 2025 was $25.4 million, up 297.0% from $6.4 million in Q3 2024, with an Adjusted EBITDA Margin of 27.7%.
• The company completed refinancing of senior secured debt, projected to reduce annualized interest expense by $10 million.
• Cash on hand stood at $117.5 million as of September 30, 2025.
• Vireo launched adult-use cannabis sales in Minnesota on September 16, 2025, across all eight Green Goods dispensaries.
• A comprehensive settlement with Verano Holdings Corp. was reached on October 29, 2025, valued at approximately $10 million for Vireo.
• The company is acquiring a majority stake in Schwazze's assets, a multi-state cannabis operator with 46 dispensaries and 2 manufacturing facilities in Colorado and New Mexico.
• Integration of recent acquisitions was largely completed by the end of Q3, with full integration expected by year-end, leading to realized corporate overhead synergies.
• Despite strong revenue growth, GAAP net loss widened to $(26.3) million in Q3 2025 from $(4.9) million in Q3 2024.

Sentiment

Score: 7

Explanation: The company demonstrated substantial revenue and adjusted EBITDA growth, driven by successful M&A and entry into new adult-use markets. Strategic debt refinancing and litigation settlement are positive for financial health. However, the widening GAAP net loss and declines in certain legacy market revenues indicate ongoing challenges in profitability and operational efficiency that need to be monitored.

Positives

• Significant GAAP revenue growth of 264.2% year-over-year to $91.7 million in Q3 2025.
• Strong Adjusted EBITDA growth of 297.0% year-over-year to $25.4 million in Q3 2025, with an improved Adjusted EBITDA Margin of 27.7%.
• Successful refinancing of senior secured debt is expected to decrease annualized interest expense by $10 million.
• Robust cash position of $117.5 million at the end of Q3 2025.
• Entry into the Minnesota adult-use cannabis market, expected to be a significant organic revenue growth catalyst.
• Strategic acquisition of a majority of Schwazze's assets expands Vireo's footprint into Colorado and New Mexico with 46 dispensaries and 2 manufacturing facilities.
• Resolution of litigation with Verano Holdings Corp. resulting in a $10 million settlement value for Vireo.
• Successful integration of recent acquisitions, leading to corporate overhead synergies and expected full completion by year-end.

Negatives

• GAAP Gross Profit Margin decreased by 820 basis points to 40.8% in Q3 2025 compared to 49.0% in Q3 2024.
• GAAP Operating Income decreased by 79.0% to $0.8 million in Q3 2025 from $3.9 million in Q3 2024, with GAAP Operating Income Margin declining by 1,460 basis points to 0.9%.
• Net loss widened significantly to $(26.3) million in Q3 2025 from $(4.9) million in Q3 2024.
• Net loss per share increased to $(0.04) in Q3 2025 from $(0.02) in Q3 2024.
• Retail revenue in New York and Maryland experienced declines of 31% and 4% respectively in Q3 2025.
• Wholesale revenue in Minnesota and Maryland experienced declines of 54% and 5% respectively in Q3 2025.

Risks

• Risks related to the timing and content of adult-use legislation in markets where the company operates.
• Current and future market conditions, including the market price of the subordinate voting shares of the Company.
• Risks related to epidemics and pandemics.
• Federal, state, local, and foreign government laws, rules, and regulations, including federal and state laws and regulations in the United States relating to cannabis operations and any changes to such laws or regulations.
• Operational, regulatory, and other risks inherent in the business.
• Risks associated with the execution of business strategy and management of growth.
• Difficulties inherent in forecasting future events.
• Potential conflicts of interest.
• Risks inherent in an agricultural business and a manufacturing business.
• Liquidity and the ability of the Company to raise additional financing to continue as a going concern.
• The Company's ability to meet the demand for flower in its various markets.
• Ability to dispose of assets held for sale at an acceptable price or at all.
• General risk factors set out in the Company's Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.

Future Outlook

The company expects to decrease annualized interest expense by $10 million following debt refinancing. Management plans to continue optimizing all areas of the business and remain opportunistic for further acquisitive growth opportunities in a distressed environment. The launch of Minnesota's adult-use cannabis market is anticipated to serve as an organic revenue growth catalyst. Full integration of recent acquisitions is expected to be completed by the end of 2025. The proposed restructuring of Schwazze's operations and capital structure, including the acquisition of a majority of its assets, is also a key future strategic move.

Management Comments

• "Our third quarter results reflect continued progress against our objective to create a portfolio of prolific brands in cannabis."
• "Performance was in line with our expectations and is beginning to demonstrate the impact of our efforts to transform the Company through accretive M&A."
• "As we exit 2025 and begin the new year, we will continue optimizing all areas of our business while remaining opportunistic with respect to further acquisitive growth opportunities."

Industry Context

Vireo Growth Inc.'s significant revenue growth, driven by M&A and expansion into adult-use markets like Minnesota, reflects a broader trend in the U.S. cannabis industry where multi-state operators are consolidating and expanding their footprint. The company's strategy to remain acquisitive in a "distressed environment" suggests it is leveraging market conditions to acquire assets at potentially favorable valuations, a common tactic among well-capitalized players in a fragmented and evolving regulatory landscape. The launch of adult-use sales in Minnesota aligns with the ongoing state-level legalization trend, providing new revenue streams for early movers. The acquisition of Schwazze assets further solidifies Vireo's position as a multi-state operator, expanding into established markets like Colorado and New Mexico.

Legal Proceedings

• Comprehensive settlement agreement reached with Verano Holdings Corp., dismissing all outstanding litigation matters between the two companies pending before the Supreme Court of British Columbia, Canada. The value of the settlement to Vireo is approximately $10 million.

Stakeholder Impact

• Shareholders: Potential for increased value due to significant revenue growth, strategic M&A, and expansion into new markets. However, widening GAAP net loss and potential dilution from future capital raises (mentioned as a risk) could be concerns. The $10M settlement is a direct positive.
• Employees: Integration of acquisitions and optimization efforts may lead to changes in roles or organizational structure. Expansion into new markets could create new opportunities.
• Customers: Expansion into adult-use markets (e.g., Minnesota, potentially Colorado/New Mexico via Schwazze) provides broader access to products.
• Creditors: Debt refinancing is expected to reduce interest expense, potentially improving the company's ability to service its debt.

Next Steps

• Continue optimizing all areas of the business.
• Remain opportunistic with respect to further acquisitive growth opportunities.
• Complete full integration of recent acquisitions by the end of 2025.
• Restructure the operations and capital structure of Schwazze and its subsidiaries, including the UCC sale of certain assets to a newly-formed entity majority-owned by Vireo, and the liquidation of Schwazze's remaining operations.

Key Dates

Recommendation

While Vireo Growth Inc. shows impressive top-line growth and strategic expansion through M&A and new market entry, the widening GAAP net loss and declining gross profit margin on a GAAP basis are significant concerns. The adjusted metrics are strong, but the GAAP figures highlight underlying profitability challenges. The company is making aggressive strategic moves, including the Schwazze acquisition and debt refinancing, which could be transformative. However, the cannabis industry remains highly volatile and regulatory risks are substantial. Given the mixed financial signals (strong adjusted performance vs. GAAP losses) and ongoing integration efforts, a "hold" recommendation is appropriate. Investors should monitor the successful integration of acquisitions, the impact of the Minnesota adult-use market, and progress towards GAAP profitability before considering a stronger position.

Keywords

Cannabis, Marijuana, Multi-state operator (MSO), Adult-use cannabis, Medical cannabis, Minnesota cannabis market, Schwazze acquisition, Verano Holdings settlement, Q3 2025 earnings, Financial results, Revenue growth, EBITDA, M&A, Refinancing, Dispensaries, Cultivation, Retail cannabis, Wholesale cannabis